BAX — BAXTER INTERNATIONAL INC
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 10456 ·
Last close
$25.76
Market Cap
$13.33B
52W High
$29.99
52W Low
$15.72
ADV30
6,615,603
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 2,960,000,000 | 1,032,000,000 | 217,000,000 | 126,000,000 | 19,791,000,000 | 2,150,000,000 | 13,612,000,000 |
| Mar 2026 | 2,701,000,000 | 891,000,000 | 66,000,000 | -15,000,000 | 19,846,000,000 | 2,017,000,000 | 13,830,000,000 |
| Dec 2025 | 2,974,000,000 | 577,000,000 | -244,000,000 | -1,128,000,000 | 20,055,000,000 | 1,966,000,000 | 13,953,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,343,000,000
Investing CF
$-475,000,000
Financing CF
$-270,000,000
CapEx
$-507,000,000
Dividends Paid
$-184,000,000
Buybacks
—
EPS Diluted TTM
$-1.41
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$13,806,000,000
Inventory
$2,259,000,000
Receivables
$1,856,000,000
ST Investments
—
EBIT TTM
$-191,000,000
Pretax Income TTM
$-483,000,000
Interest Exp TTM
$292,000,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$11,610,999,808
EBITDA
$1,832,999,936
Free Cash Flow
$1,222,499,968
Enterprise Value
$18,704,009,216
Total Cash
$1,975,000,064
Total Debt
$8,807,000,064
Shares Out
517,348,188
Trailing EPS
$-1.88
Book Value
$11.92
ROE
-9.0%
ROA
2.7%
Div Yield
0.17%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 11,244,000,000 | 177,000,000 | -957,000,000 | 20,055,000,000 | 13,953,000,000 | 6,129,000,000 | 845,000,000 |
| Dec 2024 | 10,636,000,000 | 439,000,000 | -649,000,000 | 25,782,000,000 | 18,758,000,000 | 6,964,000,000 | 1,019,000,000 |
| Dec 2023 | 10,360,000,000 | 707,000,000 | 2,656,000,000 | 28,276,000,000 | 19,808,000,000 | 8,402,000,000 | 1,726,000,000 |
| Dec 2022 | 10,057,000,000 | -33,000,000 | -2,433,000,000 | 28,287,000,000 | 22,392,000,000 | 5,833,000,000 | 1,211,000,000 |
TTM Snapshot
Revenues TTM
$11,470,000,000
NetIncome TTM
$-1,063,000,000
OpCashFlow TTM
—
Assets (Latest)
$19,791,000,000
Forward EPS
$2.04
Max Pain — expiry 2026-12-18
max pain strike: $25.00 · spot: $26.16 · call oi: 5,157 · put oi: 3,690
Expected Move to 2026-12-18:
±$2.58
(9.84%) —
implied range
$23.59 –
$28.73
· ATM straddle on $25.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SNNUF | SMITH & NEPHEW PLC | $12.93B | $15.45 | — |
| SNN | SMITH & NEPHEW PLC | $12.77B | $30.51 | — |
| PEN | Penumbra Inc | $12.58B | $319.11 | — |
| GKOS | GLAUKOS Corp | $14.40B | $243.25 | — |
| SOLV | Solventum Corp | $14.63B | $86.06 | — |
News headlines (Yahoo Finance, 1h cache)
Baxter: 3 Key Takeaways for Long-Term Investors
2026-11-18 20:50 · Yahoo
Global Gynecological Examination Chairs Market Report 2026: Size, 7% CAGR and Forecast to 2030 | Capitalize on Smart Chairs with Stryker, Baxter, STERIS and Midmark
2026-11-18 14:45 · Yahoo
How Return To Profit Will Impact Baxter International Stock (BAX)
2026-11-06 18:13 · Yahoo
Baxter International Stock: Analyst Estimates & Ratings
2026-11-04 10:29 · Yahoo
Should You Buy Baxter Stock For Its Cash?
2026-11-03 19:54 · Yahoo
BAX Q3 deep dive: cost actions and product changes shape outlook amid market caution
2026-10-30 16:02 · Yahoo
Baxter International Inc. Q3 2026 Earnings Call Summary
2026-10-30 12:30 · Yahoo
Baxter’s shares fall as Q3 probability dips despite revenue growth
2026-10-30 11:59 · Yahoo
What Baxter International (BAX) Said on Its Q3 Earnings Call
2026-10-30 07:14 · Yahoo
Baxter International (BAX) Received An FDA Warning Letter Over CGMP Violations
2026-10-30 01:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.